A study on the evaluation of pre-treatment for forensic toxicological drug screening

法医毒理学药物筛查前处理评价研究

基本信息

  • 批准号:
    06670474
  • 负责人:
  • 金额:
    $ 0.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Different solid-phase extraction methods for the screenign of drugs prior to gas chromatography with nitrogen-phosphorus detection were compared The extractions including Bond Elut (Certify, CN,C18, C8), Chem Elut, Clean Screen DAU and Extrelut, were evaluated both by the absolute recoveries of 15 drugs from whole blood and by the degree of interferences from blank blood on the analysis of these drugs The mean absolute recoveries from the cartridge columns were 72.9,60.2,61.3,62.1,56.8,86.3, and 67.6%, with the coefficients of variation being 9.7,11.7,14.2,16.6,13.0,7.8, and 11.9%, respectively (the values of Bond Elut Certify and Clean Screen DAU are for 13 basiccompounds). The interferences from blank blood on the analysis of drugs were the smallest with Clean Screen DAU (basic extraction alone), and progressively greater on Bond Elut CN,Bond Elut Certify (basic extraction alone), Extrelut, Bond Elut C8, Bond Elut C18 and Chem Elut. The detection limits of the drugs in whole blood from Extrelut and Clean Screen DAU (basic drugs alone) were from 0.005 to 0.1 and from 0.005 to 0.02 mg/ml, respectively In conclusion, this study suggests that Clean Screeen DAU (for basic compounds) and Extrelut are the most suitable disposable cartridges for the routine screening of drugs in forensic toxicological analysis.
不同的固相萃取方法的screenign药物之前,气相色谱法与氮磷检测比较拔掉包括债券Elut(证明,CN、C18 C8),化学Elut,清洁屏幕道和Extrelut,进行评估通过15的绝对复苏药物从全血和血液从空白干扰的程度在分析这些药物的平均绝对复苏墨盒列分别为72.9,60.2,61.3,62.1,56.8,86.3,和67.6%,变异系数分别为9.7、11.7、14.2、16.6、13.0、7.8和11.9% (Bond Elut Certify和Clean Screen DAU分别为13种基本化合物)。空白血对药物分析的干扰在Clean Screen DAU(单纯基础萃取物)上最小,在Bond Elut CN、Bond Elut Certify(单纯基础萃取物)、Extrelut、Bond Elut C8、Bond Elut C18和Chem Elut上逐渐增大。exrelut全血药物检出限为0.005 ~ 0.1 mg/ml, Clean Screen DAU(单纯基础药物)检出限为0.005 ~ 0.02 mg/ml。综上所示,Clean Screen DAU(单纯基础药物)和exrelut是法医毒理学分析中常规药物筛查最合适的一次性药盒。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAGEURA Mitsuyoshi其他文献

KAGEURA Mitsuyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAGEURA Mitsuyoshi', 18)}}的其他基金

STUDY ON STRATEGY TO ESTABLISH FORENSIC TOXICOLOGY LABORATORY GUIDELINES IN JAPAN
日本建立法医毒理学实验室指南的策略研究
  • 批准号:
    18590648
  • 财政年份:
    2006
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on strategy to establish quality assurance/quality control system in Japanese forensic toxicology practices.
日本法医毒理学实践中建立质量保证/质量控制体系的策略研究。
  • 批准号:
    14370158
  • 财政年份:
    2002
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications.
STTR 第二阶段:用于药物筛选应用的片上内皮微流体装置的优化制造和基于机器学习的自动化。
  • 批准号:
    2332121
  • 财政年份:
    2024
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Cooperative Agreement
Development of a 3D-printed anisotropic heart-on-a-chip for drug screening applications
开发用于药物筛选应用的 3D 打印各向异性芯片心脏
  • 批准号:
    EP/X02721X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Fellowship
COVID-19 Drug-Screening and Resistance Hub (CRUSH)
COVID-19 药物筛选和耐药性中心 (CRUSH)
  • 批准号:
    MC_UU_00034/9
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Intramural
Development of a 3D-printed anisotropic heart-on-a-chip for drug screening applications
开发用于药物筛选应用的 3D 打印各向异性芯片心脏
  • 批准号:
    EP/X02721X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Fellowship
Functional single cell analysis and drug screening in tumor organoids to target slow-growing cells
针对生长缓慢的细胞的肿瘤类器官功能性单细胞分析和药物筛选
  • 批准号:
    22KF0212
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Hair follicle organoid model for drug screening
用于药物筛选的毛囊类器官模型
  • 批准号:
    23K13614
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of a novel therapeutic strategy for angiosarcoma through drug screening
通过药物筛选开发血管肉瘤新治疗策略
  • 批准号:
    23K07757
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
  • 批准号:
    23K07918
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024.
授予 NIMH 精神活性药物筛查计划 (PDSP) 基期。
  • 批准号:
    10931140
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
PFI-TT: Validation of a Modular Osteoarthritis Disease Model System for Early Stage Pharmaceutical Drug Screening
PFI-TT:用于早期药物筛选的模块化骨关节炎疾病模型系统的验证
  • 批准号:
    2234590
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了